Mutations in the Presenilin genes (PSEN1 and PSEN2) account for > 80% of all identified causative mutations in familial AD, highlighting the importance of Presenilin (PS) in AD pathogenesis. This evidence concerns the gene PSEN2 and Alzheimer disease.